收稿日期: 2025-09-11
网络出版日期: 2026-02-09
基金资助
国家自然科学基金项目(81373421);安徽省自然科学资金项目(2108085MH264)
Effect of resveratrol mediated by the PINK1/Parkin pathway on fibroblast-like synovial cells of osteoarthritis treated with H2O2
Received date: 2025-09-11
Online published: 2026-02-09
目的 探讨白藜芦醇(Res)对H2O2处理的骨关节炎成纤维样滑膜细胞的影响,并阐明PINK1/Parkin线粒体自噬信号通路在上述影响中的调控机制关系。 方法 从无骨关节炎手术患者关节滑膜提取成纤维样滑膜细胞(FLSs),从骨关节炎手术患者关节滑膜提取成纤维样滑膜细胞(OA-FLSs),并将其分为对照组、实验组,实验组用H2O2(5 μmol/L)处理后,应用不同浓度的Res(0、10、20、40、60、80、100 μmol/L)处理,细胞活力测定(CCK-8)检测细胞增殖抑制率,DCFH-DA荧光探针检测细胞活性氧,MitoSOX Red荧光探针检测细胞线粒体活性氧,流式细胞术检测细胞周期,Western blot以及免疫荧光实验检测NLRP3、TNF-α、IL-1β、SOD2、Bax、Bcl-2、BNIP3、LC3B、p62、PINK1、Parkin等蛋白的表达。使用PINK1、Parkin干扰RNA进一步验证PINK1/Parkin线粒体自噬信号通路在Res抑制FLSs异常增殖、炎症和氧化应激中的作用。 结果 Res显著抑制H2O2诱导的FLSs活力的增强,且抑制效果与浓度成正比;Res降低了FLSs的异常增殖、炎症和氧化应激水平;Res抑制了NLRP3、TNF-α、Bcl-2、p62蛋白的表达,同时促进SOD2、Bax、BNIP3、LC3B、PINK1、Parkin蛋白的表达;H2O2抑制了PINK1/Parkin信号通路,Res则激活了PINK1/Parkin通路;PINK1和Parkin干扰RNA的使用加剧了细胞炎症和氧化应激。 结论 Res通过增加PINK1和Parkin蛋白的表达来激活PINK1/Parkin线粒体自噬信号通路,减轻了H2O2诱导的骨关节炎成纤维样滑膜细胞中异常增殖、炎症和氧化应激。
张丽霞 , 范学菲 , 陈苏环 , 张梦妍 , 邵玉宝 , 周剑 , 陈晓宇 . PINK1/Parkin通路介导的白藜芦醇对H2O2处理的骨关节炎成纤维样滑膜细胞的影响[J]. 实用医学杂志, 2026 , 42(3) : 363 -370 . DOI: 10.3969/j.issn.1006-5725.2026.03.002
Objective To investigate the effect of resveratrol (Res) on fibroblast-like synovial cells of osteoarthritis treated with H2O2, and to clarify the regulatory mechanism relationship of the PINK1/Parkin mitochondrial autophagy signaling pathway in the above effects. Methods Fibroblast-like synovial cells (FLSs) were extracted from the synovial membranes of patients undergoing osteoarthritis surgery and divided into the control group and the experimental group. The experimental group was treated with H2O2 (5 μmol/L) and then treated with different concentrations of Res (0, 10, 20, 40, 60, 80, 100 μmol/L). Cell viability assay (CCK-8) was used to detect the inhibition rate of cell proliferation. Cell reactive oxygen species were detected by DCFH-DA fluorescent probe. Mitochondrial reactive oxygen species were detected by MitoSOX Red fluorescent probe. Cell cycle was detected by flow cytometry. The expressions of proteins such as NLRP3, TNF-α, IL-1β, SOD2, Bax, Bcl-2, BNIP3, LC3B, p62, PINK1 and Parkin were detected by Western blot and immunofluorescence experiments. The role of the PINK1/Parkin mitochondrial autophagy signaling pathway in Res' inhibition of abnormal proliferation, inflammation and oxidative stress in FLSs was further verified using PINK1 and Parkin interfering RNA. Results Res significantly inhibited the enhancement of FLSs activity induced by H2O2, and reduced the abnormal proliferation, inflammation and oxidative stress levels of FLSs; Res inhibited the expressions of NLRP3, TNF-α, Bcl-2 and p62 proteins, while promoting the expressions of SOD2, Bax, BNIP3, LC3B, PINK1 and Parkin proteins. H2O2 inhibited the PINK1/Parkin signaling pathway, while Res activated the PINK1/Parkin pathway. The use of PINK1 and Parkin interfering RNA exacerbated cellular inflammation and oxidative stress. Conclusion Res activates the PINK1/Parkin mitochondrial autophagy signaling pathway by increasing the expression of PINK1 and Parkin proteins, alleviating abnormal proliferation, inflammation and oxidative stress in fibroblast-like synovial cells of osteoarthritis induced by H2O2.
| [1] | SHAO Z G, WANG T, YAN X M, et al. Identification of a RANKL/TNF-α dual-inhibitor as a potential disease-modifying agent for the treatment of knee osteoarthritis[J]. J Med Chem, 2025, 68(10): 10216-37. doi: 10.1021/acs.jmedchem. 5c00394 . |
| [2] | YAO Y, CAO J, DING C Z. Mesenchymal stem cells improve osteoarthritis by secreting superoxide dismutase to regulate oxidative stress response[J]. BMC Musculoskelet Disord, 2025, 26(1): 409. doi: 10.1186/s12891-025-08670-4 . |
| [3] | PAULISSEN G, MALAISE O, DEROYER C, et al. JAK inhibitors alleviate metabolic dysregulation, inflammation and fibrosis in osteoarthritis: Insights from human joint cells and synovium[J]. Rheumatology (Oxford), 2025, 64(10): 5539-5550. doi: 10.1093/rheumatology/keaf298 . |
| [4] | ZHOU R, FU W, VASYLYEV D, et al. Ion channels in osteoarthritis: Emerging roles and potential targets[J]. Nat Rev Rheumatol, 2024, 20(9):545-564. doi: 10.3724/abbs.2024102 . |
| [5] | GE M, SUN W, XU T, et al. Multi-omics analysis of synovial tissue and fluid reveals differentially expressed proteins and metabolites in osteoarthritis[J]. J Transl Med, 2025, 23(1):285. doi: 10.1186/s12967-025-06310-y . |
| [6] | ZHOU J, LI X Y, HAN Z Y, et al. Acetyl-11-keto-β-boswellic acid restrains the progression of synovitis in osteoarthritis via the Nrf2/HO-1 pathway[J]. Acta Biochim Biophys Sin (Shanghai), 2024, 56(11): 1644-58. doi: 10.3724/abbs.2024102 . |
| [7] | LIU H, ZHU Y L, GAO Y T, et al. NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis[J]. Cell Death Dis, 2020, 11(2): 129. doi: 10.1038/s41419-020-2314-6 . |
| [8] | QI W, JIN L, HUANG S, et al. Modulating synovial macrophage pyroptosis and mitophagy interactions to mitigate osteoarthritis progression using functionalized nanoparticles[J]. Acta Biomate, 2024, 181:425-439. doi: 10.1016/j.actbio.2024.05.014 . |
| [9] | ELDEEB M A, THOMAS R A, RAGHEB M A, et al. Mitochondrial quality control in health and in Parkinson's disease[J]. Physiol Rev, 2022, 102(4): 1721-55. doi: 10.1152/physrev. 00041.2021 . |
| [10] | LIU X L, WANG Z G, QIAN H, et al. Natural medicines of targeted rheumatoid arthritis and its action mechanism[J]. Front Immunol, 2022, 13: 945129. doi: 10.3389/fimmu.2022.945129 . |
| [11] | ZHANG Z Z, HUANG T Y, CHEN X, et al. Acetyl zingerone inhibits chondrocyte pyroptosis and alleviates osteoarthritis progression by promoting mitophagy through the PINK1/parkin signaling pathway[J]. Int Immunopharmacol, 2025, 161: 115055. doi: 10.1016/j.intimp.2025.115055 . |
| [12] | HRIDAYANKA K S N, DUTTAROY A K, BASAK S. Bioactive compounds and their chondroprotective effects for osteoarthritis amelioration: A focus on nanotherapeutic strategies, epigenetic modifications, and gut microbiota[J]. Nutrients, 2024, 16(21): 3587. doi: 10.3390/nu16213587 . |
| [13] | 邓 刚, 朱立新, 郭家松, 等.中药小分子治疗骨关节炎的研究进展[J].实用医学杂志, 2024, 40(23): 3389-3393. doi:10.3969/j.issn.1006-5725 . |
| [14] | JURI? I, KELAM N, RACETIN A, et al. WNT signaling factors as potential synovial inflammation moderators in patients with hip osteoarthritis[J]. Biomedicines, 2025, 13(4): 995. doi: 10.3390/biomedicines13040995 . |
| [15] | LU H, WEI J, LIU K, et al. Radical-scavenging and subchondral bone-regenerating nanomedicine for osteoarthritis treatment[J]. ACS Nano, 2023, 17(6):6131-6146. doi: 10.1021/acsnano.3c01789 . |
| [16] | SHENG W, LIAO S, CAO S, et al. Reactive oxygen species-sensitive fenofibrate-loaded dextran nanoparticles in alleviation of osteoarthritis[J]. Carbohydr Polym, 2025, 347:122768. doi: 10.1016/j.carbpol.2024.122768 . |
| [17] | NARENDR D P, YOULE R J. The role of PINK1-Parkin in mitochondrial quality control[J]. Nat Cell Biol, 2024, 26(10):1639-1651. doi: 10.1038/s41556-024-01513-9 . |
| [18] | LEE S Y, AN H J, KIM J M, et al. PINK1 deficiency impairs osteoblast differentiation through aberrant mitochondrial homeostasis[J]. Stem Cell Res Ther, 2021, 12(1):589. doi: 10.1186/s13287-021-02656-4 . |
| [19] | SHAITO A, POSADINO A M, YOUNES N, et al. Potential adverse effects of resveratrol: A literature review[J]. Int J Mol Sci, 2020, 21(6): 2084. doi: 10.3390/ijms21062084 . |
| [20] | PIGNET A L, SCHELLNEGGER M, HECKER A, et al. Resveratrol-induced signal transduction in wound healing[J]. Int J Mol Sci, 2021, 22(23): 12614. doi: 10.3390/ijms222312614 . |
| [21] | PYO I S, YUN S, YOON Y E, et al. Mechanisms of aging and the preventive effects of resveratrol on age-related diseases[J]. Molecules, 2020, 25(20): 4649. doi: 10.3390/molecules25204649 . |
/
| 〈 |
|
〉 |